Holistick is dedicated to the development of innovative medical devices to treat septal defects between the right and left heart, such as patent foramen ovale (PFO). PFO closure is correlated with a significant reduction in the risk of secondary strokes. PFO closure devices currently in use take up a lot of space and are metallic, making subsequent interventional procedures difficult. Holistick proposes a non-metallic, minimalist implant that takes up very little space and will facilitate subsequent interventional procedures.
See website
Synoptical view
- First investment date
- 2017
Management team
They talk about it
We purchased a worldwide exclusive license for the technology from Harvard University and MIT, and worked on patenting to develop the medical device
